Plerixafor

In the US, Plerixafor (plerixafor systemic) is a member of the following drug classes: hematopoietic stem cell mobilizer, other immunostimulants and is used to treat Multiple Myeloma and Non-Hodgkin's Lymphoma.

US matches:

• Plerixafor


• Plerixafor Subcutaneous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L03AX16

CAS registry number (Chemical Abstracts Service)

0110078-46-1

Chemical Formula

C28-H54-N8

Molecular Weight

502

Therapeutic Category

Antineoplastic agent

Chemical Names

1,1'-(1,4-phenylenebismethylene)bis(1,4,8,11-tetraazacyclotetradecane) (WHO)

1,4,8,11-Tetraazacyclotetradecane, 1,1'-[1,4-phenylenebis(methylene)]bis- (USAN)

Foreign Names

• Plerixaforum (Latin)
• Plerixafor (German)
• Plérixafor (French)
• Plerixafor (Spanish)

Generic Names

• Plerixafor (OS: USAN)
• AMD3100 (IS: USAN)
• JM 3100 (IS: DataStar)
• SDZ-SID-791 (IS: DataStar)
• UNII-S915P5499N (IS: USAN)

Brand Names

• Mozobil
  Genzyme, Germany; Genzyme, France; Genzyme, United Kingdom; Genzyme, Greece; Genzyme, Sweden; Genzyme, United States

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.